Dr. Lubarsky has led UC Davis Health since 2018, according to a Dec. 11 news release from WMCHealth. He will retire from his current role Feb. 15 and take over as CEO of WMCHealth on Feb. 17. The New York system includes more than 1,700 beds across eight counties in the Hudson Valley region and employs more than 13,000 people. Its flagship campus is Westchester Medical Center, a 415-bed academic hospital.
“Dr. Lubarksy is a visionary leader with demonstrated success managing complex healthcare organizations, driving financial and operational excellence with an emphasis on quality of care, expanding community access to care and improving the patient experience,” Zubeen Shroff, chairman of the Westchester County Health Care Corp., said in the release.
During Dr. Lubarsky’s tenure at UC Davis Health, patient volumes across the system grew by more than 60%. He spearheaded several community-based initiatives aimed at improving access to care for underserved populations in the region, including Medi-Cal patients and people experiencing homelessness.
He succeeds Michael Israel, who announced plans to retire as president and CEO of WMCHealth in April after nearly two decades in the role. UC Davis Health plans to announce Dr. Lubarsky’s interim successor in late January.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
